Characterization of a Nanovaccine Platform Based on an α1,2- Mannobiose Derivative Shows Species-non-specific Targeting to Human, Bovine, Mouse, and Teleost Fish Dendritic Cells

Dendritic cells serve as the main immune cells that trigger the immune response. We developed a simple and cost-effective nanovaccine platform based on the α1′,2-mannobiose derivative for dendritic cell targeting. In previous work, we have formulated the α1,2-mannobiose-based nanovaccine platform wi...

Full description

Bibliographic Details

Main Authors:	Pappalardo, Juan Sebastián, Salmaso, Stefano, Levchenko, Tatyana S., Mastrotto, Francesca, Bersani, Sara, Vermeulen, Monica, Ghersa, Federica, Quattrocchi, Valeria, Zamorano, Patricia Ines, Hartner, William C., Toniutti, Micaela, Musacchio, Tiziana, Torchilin, Vladimir P.
Format:	Artículo
Language:	Inglés
Published:	ACS Publications 2021
Subjects:	Nanomedicina Vacuna Antígenos Respuesta Inmunológica Nanomedicine Vaccines Antigens Immune Response Nanovacuna Células Dendríticas
Online Access:	http://hdl.handle.net/20.500.12123/9742 https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.1c00048 https://doi.org/10.1021/acs.molpharmaceut.1c00048